Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Cadrenal Therapeutics, Inc. reported that Chairman, CEO, and Interim CFO Pham Quang X sold 18,124 shares of the company's common stock for a total value of $70,351. The transactions were executed over three days in mid-June 2026 under a Rule 10b5-1 trading arrangement established in September 2025. This insider activity occurs as the company's stoc…
Oliver Engert, Chief Administrative Officer at Enovis Corporation (NASDAQ: ENOV), executed a $25,948 stock acquisition on June 11, 2026, purchasing 1,200 shares across two transactions priced between $20.99 and $21.75 per share. This insider activity occurs while ENOV stock hovers near its 52-week low of $20.55, reflecting a 12% decline over the pa…
Eric Lentell, the Chief Legal and Strategy Officer at Archer Aviation Inc., executed a transaction on June 11, 2026, selling 3,754 shares of the company's Class A Common Stock. The total value of this sale was $18,763. This activity was necessitated by the need to satisfy tax withholding obligations resulting from the vesting of restricted stock un…
CrowdStrike Holdings, Inc. (NASDAQ: CRWD) President and CEO George Kurtz executed a series of stock sales totaling $2,478,758 in mid-June 2026. The transactions, conducted under a pre-arranged 10b-1 plan adopted in early January, involved the sale of 3,497 Class A common shares. This divestment occurs amidst a period of strong stock performance and…
Puma Biotechnology director Troy E. Wilson executed a sale of 10,800 shares under a pre-arranged trading plan, while also receiving restricted stock units earlier in the week. The transaction occurs as the company reports first-quarter 2026 results that missed analyst expectations on both earnings per share and revenue. The stock has experienced si…
Viant Technology Inc. (NASDAQ:DSP) Chief Operating Officer Christopher Vanderhook executed a sale of 9,125 shares on June 15, 2026, generating proceeds of $101,287. The transaction was structured to cover estimated tax obligations arising from the vesting and settlement of restricted stock units. At the time of execution, the shares were valued at …
Viant Technology Inc. (NASDAQ:DSP) Chief Executive Officer and Chairman Timothy Vanderhook executed a sale of 9,125 Class A Common Stock shares on June 15, 2026. The transaction, valued at $101,287, was conducted at an average price of $11.10 per share. This divestment was necessitated by estimated tax liabilities associated with the vesting and se…
Aden Allison, Executive Vice President and Chief Financial Officer at Cavco Industries, Inc. (NASDAQ: CVCO), executed a series of stock sales on June 12, 2026, totaling $740,804. The transactions involved the liquidation of 1,208 shares at $600.00 per share and the surrender of 27 shares at $592.76 per share to satisfy tax withholding obligations. …
Voss Capital, LP, has significantly increased its position in PAR Technology Corp (NYSE:PAR), acquiring approximately $5.06 million worth of shares between June 11 and June 12, 2026. This move brings the fund's managed accounts to hold 5,125,000 shares, contributing to a collective beneficial ownership of over 10% of the company's outstanding commo…
Arif Janmohamed, a director at Navan, Inc. (NASDAQ: NAVN), has completed the sale of approximately $40.8 million in Class A Common Stock. The transactions, executed indirectly through the Lightspeed Opportunity Fund, L.P., occurred on June 12 and June 15, 2026. This divestment takes place against a backdrop of robust operational performance for Nav…
Lightspeed Opportunity Fund, L.P., a significant ten percent owner of Navan Inc. (NASDAQ: NAVN), executed sales totaling approximately $40.8 million in the company's Class A Common Stock between June 12 and June 15, 2026. The transactions occurred at share prices ranging from $19.77 to $20.91, with the fund disposing of 2,024,131 shares in total. T…
CrowdStrike Holdings, Inc. (NASDAQ:CRWD) President and CEO George Kurtz sold $940,202 worth of Class A common stock on June 11, 2026. The transaction, executed under a 10b5-1 trading plan established in January 2026, involved the sale of 1,402 shares priced between $643.58 and $685.46. Following the sale, Kurtz retains direct ownership of 2,125,688…
Multiple funds affiliated with Lightspeed have executed significant divestments in Navan (NASDAQ: NAVN) stock over the past week. The transactions follow a substantial six-month price appreciation and coincide with positive fundamental developments reported by the company. Analysts have responded to the recent earnings data by raising price targets…
Paul Funk II, a director at Red Cat Holdings, Inc. (NASDAQ:RCAT), executed a significant divestment of company shares on June 11, 2026. The transaction involved the sale of 165,028 shares, generating proceeds of approximately $1,897,822. This sale occurred as Red Cat Holdings continues to expand its operational footprint in the defense drone sector…
Jay M. Moyes, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), sold 22,000 shares for $158,796 on June 12, 2026, under a 10b5-1(c) plan. This sale occurred shortly after he received 27,000 RSU shares and amidst a challenging first-quarter 2026 earnings report that missed analyst expectations for both revenue and net income. The transaction hig…
Gerhard Watzinger, a director at CrowdStrike Holdings, Inc. (NASDAQ:CRWD), recently executed a significant divestment of company stock, selling approximately $1.71 million worth of shares in mid-June 2026. This transaction, filed with the Securities and Exchange Commission, highlights executive-level portfolio adjustments against a backdrop of robu…
Gevo, Inc. (NASDAQ:GEVO) President and COO Ryan Christopher Michael executed a sale of 35,196 shares of common stock on June 12, 2026, totaling $50,161. The transaction was conducted under a pre-arranged 10b5-1 trading plan established in November 2025 to fulfill tax withholding obligations linked to the vesting of a restricted stock award. Followi…
Brian M. Stuglik, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), sold 8,100 shares of the company’s common stock for a total of $58,311 on June 12, 2026. The transaction was conducted under a pre-arranged 10b5-1 trading plan, which was adopted on March 12, 2025. The sale followed an acquisition of 27,000 shares of common stock by Mr. Stuglik…
Adrian Senderowicz, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), has executed a sale of 27,000 shares of common stock valued at $194,310 on June 12, 2026, according to a Securities and Exchange Commission filing. The transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted on March 12, 2025. This sale immediately …
Century Therapeutics, Inc. (NASDAQ: IPSC) reported a recent insider transaction involving Senior Vice President of Finance and Operations Douglas Carr, who disposed of 1,654 shares on June 12, 2026. The sale, valued at $3,691, was executed at $2.232 per share and was not discretionary, serving to cover tax withholding obligations tied to the vestin…
Allison Dorval, a director at PUMA BIOTECHNOLOGY, INC. (NASDAQ:PBYI), has executed a series of significant share transactions, selling 11,610 shares for $83,579 under a pre-arranged 10b5-1 trading plan. This activity follows her acquisition of 27,000 restricted stock units on the preceding day. The insider movement occurs against a backdrop of a 10…
Comstock Inc. director Steven Pei increased his indirect ownership in the company through two separate transactions in mid-June 2026, bringing his total holdings to 1,868,323 shares. The acquisitions were executed through Gratia Capital and coincide with a period of significant stock price recovery for LODE. The company also recently finalized a tr…
Gregory Russotti, serving as the Chief Technology and Manufacturing Officer at Century Therapeutics, Inc. (NASDAQ: IPSC), executed a transaction involving the sale of 2,584 shares of the company's common stock on June 12, 2026. The total value of the sale was $5,767, with each share transacted at a price of $2.232. This activity was necessitated by…
Dawn Christine Maroney, president of Alignment Healthcare Inc. (NASDAQ: ALHC), sold 30,000 shares of the company’s common stock on June 15, 2026, under a pre-arranged Rule 10b5-1 trading plan. The transaction, valued at $586,425, brings her direct holdings to 947,313 shares. This sale follows a period of strong financial performance for the company…
Sonida Senior Living, Inc. (NASDAQ:SNDA) director Benjamin P. Harris executed a direct sale of 2,500 shares on May 13, 2026, totaling $93,654 at a price of $37.4618 per share. This transaction leaves Harris with a remaining direct holding of 9,182 shares. The sale occurred as SNDA shares traded at $34.58, below the transaction price, despite the st…
